Drug Shortage Report for MINT-ATORVASTATIN
Report ID | 217690 |
Drug Identification Number | 02479508 |
Brand name | MINT-ATORVASTATIN |
Common or Proper name | Atorvastatin |
Company Name | MINT PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | ATORVASTATIN |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 500 count bottle |
ATC code | C10AA |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-01-18 |
Estimated end date | 2024-04-30 |
Actual end date | 2024-01-29 |
Shortage status | Resolved |
Updated date | 2024-01-30 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2024-01-30 | English | Compare |
v4 | 2024-01-29 | French | Compare |
v3 | 2024-01-29 | English | Compare |
v2 | 2024-01-29 | French | Compare |
v1 | 2024-01-29 | English | Compare |
Showing 1 to 5 of 5